Ketamine's Antidepressant Actions: Potential Mechanisms in the Primate Medial Prefrontal Circuits That Represent Aversive Experience
- PMID: 27079495
- PMCID: PMC5458412
- DOI: 10.1016/j.biopsych.2016.02.014
Ketamine's Antidepressant Actions: Potential Mechanisms in the Primate Medial Prefrontal Circuits That Represent Aversive Experience
Conflict of interest statement
AFTA and Yale University receive royalties from the sales of Intuniv (extended release guanfacine) in the United States from Shire Pharmaceuticals but not from generic formulations. All other authors report no biomedical financial interests or potential conflicts of interest.
Figures
Comment on
-
Large-Scale Persistent Network Reconfiguration Induced by Ketamine in Anesthetized Monkeys: Relevance to Mood Disorders.Biol Psychiatry. 2016 May 1;79(9):765-775. doi: 10.1016/j.biopsych.2015.02.028. Epub 2015 Feb 27. Biol Psychiatry. 2016. PMID: 25837427
References
-
- Lv Q, Yang L, Li G, Wang Z, Shen Z, Yu W, et al. Large-scale persistent network reconfiguration induced by ketamine in anesthetized monkeys: Relevance to mood disorders. Biol Psychiatry. 2016;79:765–775. - PubMed
-
- Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–660. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
